Mrs. Barbara Paulk Mcclellan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 35 Jefferson Street, Buy Rite Drugs, Chattahoochee, FL 32324 Phone: 850-663-5700 |
Melanie Marie Niehus, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1565 Glen Julia Rd, Chattahoochee, FL 32324 Phone: 850-345-1464 |
Charles Anthony Hurst Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12 Decatur St, Chattahoochee, FL 32324 Phone: 850-663-2268 Fax: 850-663-3923 |
Dr. Maegan Wester Kirkland, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12 Decatur St, Chattahoochee, FL 32324 Phone: 850-663-4425 Fax: 850-663-3923 |
News Archive
Escalon Medical Corp. (NASDAQ: ESMC) today announced its operating results for the fiscal year ended September 30, 2014.
Kessler Foundation has been awarded a new grant by the National Multiple Sclerosis Society for a pilot study of memory and learning difficulties in individuals with MS. Scientists will test the effectiveness of using of self-generated learning in a treatment intervention to improve memory and functional performance.
Victoria will be home to one of Australia's fastest supercomputers and the world's greenest supercomputer, the IBM Blue Gene/Q, which will be housed at the Victorian Life Sciences Computation Initiative (VLSCI) hosted by the University of Melbourne, and is aimed at advancing the study of human disease.
Family breakdown and the insecure financial situation that may result is more likely to cause worry, anxiety and depressive symptoms in adolescents who are separated from their father, says Professor Jennifer O'Loughlin of the University of Montreal. However, these symptoms can disappear in the nine-month period following the separation. O'Loughlin came to these conclusions after conducting a study that was recently published in the Canadian Journal of Psychiatry.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
› Verified 1 days ago